Dr. Van Tine Discusses Identifying Biomarkers in Sarcomas

Dr. Van Tine Discusses the Development of Olaratumab in SarcomaПодробнее

Dr. Van Tine on Collaboration and Clinical Trials in Uterine SarcomaПодробнее

Dr. Van Tine Discusses Potential Novel Treatment Modalities for SarcomaПодробнее

Dr. Van Tine on Arginine Deiminase for SarcomasПодробнее

Predicative biomarkers of response to immunotherapy in STSПодробнее

Predictive biomarkers of response to immunotherapy in soft tissue sarcomaПодробнее

Hot topics in sarcoma at ASCO 2021Подробнее

The role of biomarkers in soft tissue sarcoma treatment and researchПодробнее

Addressing the lack of sarcoma biomarkersПодробнее

Updates in Sarcoma: 2023 West OncologyПодробнее

An Analysis of SARC021Подробнее

Brian Van Tine, ESMO 2019 - Pazopanib in soft tissue sarcomasПодробнее

ASCO 2013 - Brian Van Tine M.D., PH.D., Molecular ProfilingПодробнее

Understanding Molecular Subtypes of SarcomaПодробнее

Dr. Van Tine - A Medical Oncologist Perspective on STARПодробнее

Dr. Van Tine on Sequencing Therapies in GISTПодробнее

Brian Van Tine, MD, considers the role of real-world outcomes in the treatment of sarcomaПодробнее

Potential Novel Treatment Modalities for SarcomaПодробнее

Brian Van Tine, ASCO20: Summary of the Phase 1 SPEARHEAD-1 Trial in SarcomaПодробнее